- Q1 2024 Heron Therapeutics Inc Earnings Call TranscriptMay 07, 2024€2.85 (+10.71%)Earnings
- Q4 2023 Heron Therapeutics Inc Earnings Call TranscriptMar 12, 2024€2.16 (-7.69%)Earnings
- Q3 2023 Heron Therapeutics Inc Earnings Call TranscriptNov 14, 2023€0.525 (-6.25%)Earnings
- Q2 2023 Heron Therapeutics Inc Earnings Call TranscriptAug 14, 2023€1.46 (-0.68%)Earnings
- Q1 2023 Heron Therapeutics Inc Earnings Call TranscriptMay 11, 2023€2.08 (-5.45%)Earnings
- Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Q4 2022 Heron Therapeutics Inc Earnings Call TranscriptMar 23, 2023€1.9 (-0.06%)Earnings
- Q3 2022 Heron Therapeutics Inc Earnings Call TranscriptNov 08, 2022€3.37 (+1.05%)Earnings
- Heron Therapeutics Inc Investor Call TranscriptSep 19, 2022
- Q2 2022 Heron Therapeutics Inc Earnings Call TranscriptAug 09, 2022€4.18 (+20.54%)Earnings
- Q1 2022 Heron Therapeutics Inc Earnings Call TranscriptMay 09, 2022€3.81 (+1.18%)Earnings
- Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Q4 2021 Heron Therapeutics Inc Earnings Call TranscriptFeb 28, 2022€6.28 (-5.54%)Earnings
- Heron Therapeutics Inc Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF TranscriptDec 09, 2021
- Q3 2021 Heron Therapeutics Inc Earnings Call TranscriptNov 03, 2021€9.69 (-0.23%)Earnings
- Heron Therapeutics Inc to Host U.S. FDA Approval of ZYNRELEFâ„¢ - Conference Call TranscriptMay 13, 2021
- Heron Therapeutics Inc 2020 Conference Call TranscriptJun 29, 2020
- Heron Therapeutics Inc Annual Shareholders Meeting TranscriptJun 17, 2020
- Heron Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Heron Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Heron Therapeutics Inc to discuss the Complete Response Letter - Conference Call TranscriptMay 01, 2019
Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Hi, good morning. I'm Serge Belanger, one of the senior healthcare analysts at Needham. Want to welcome you to our 22nd Annual Healthcare Conference.
And for our next session, we're happy to have with us the new CEO of Heron Therapeutics, Craig Collard. He's going to give us an overview of the company, then we'll jump to Q&A. For those listening in on the conference portal, you do have the option to submit questions. It should be at the bottom of the screen you're currently looking at.
So, Craig, I'll hand it over to you. I know it's only been a few weeks in the new seat, but looking forward to speaking with you about Heron today.
Okay. Thanks, Serge. I'll really just give a brief overview of the company. Again, I've been here two weeks and came into this fairly fast [activist] group that came into the company. I joined originally as a Board member and wasn't really anticipating jumping right into the CEO role, and that became available.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)